Treatment Indications: correction of superficial fine lines and delicate wrinkles (including perioral and periorbital zones),, subtle volumization in thin‑skinned areas requiring a low‑viscosity, highly malleable gel;, refinement of lip borders and mild tissue depressions where a smooth, natural result is critical.
Release form: 1 × 0.7 mL pre‑filled syringe
Compound: cross‑linked hyaluronic acid (non‑animal origin, produced via biofermentation) with optimized particle size for superficial placement; lidocaine hydrochloride; phosphate‑buffered saline solution.
Concentration of GC: 20 mg/mL
Lidocaine: 0.3%
Indications: superficial dermal correction requiring a soft, cohesive gel with low storage modulus (G’) for minimal palpability;, smoothing of fine textural irregularities, delicate contour refinement, and natural‑looking enhancement in mobile or sensitive zones (e.g., lips, under‑eye hollows).